Cardio Diagnostics Holdings (CDIO) Interest Coverage Ratio (2021 - 2026)
Cardio Diagnostics Holdings (CDIO) posted Interest Coverage Ratio of 27.2 for Q1 2026, up 95.74% sequentially from 638.4 in Q4 2025, and down 8.16% YoY from 29.62 in Q1 2025.
Cardio Diagnostics Holdings (CDIO) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Cardio Diagnostics Holdings has reported Interest Coverage Ratio for 6 years, with the latest figure at 27.2 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 8.16% year-over-year to 27.2 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 48.86 (down 5527.94% YoY) and the FY2025 annual result came in at 24.88, down 1567.69% from the prior year.
- Interest Coverage Ratio advanced to 27.2 in Q1 2026 per CDIO's latest filing, from 638.4 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 0.23 in Q4 2023 and troughed at 638.4 in Q4 2025.
- A 5-year average of 119.69 and a median of 9.84 in 2025 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2023 and 2024: Interest Coverage Ratio surged 100.06% in 2023, then tumbled 208213.64% in 2024.
- Over 5 years, Interest Coverage Ratio stood at 407.97 in 2022, then soared by 100.06% to 0.23 in 2023, then sank by 208213.64% to 484.94 in 2024, then plunged by 31.65% to 638.4 in 2025, then soared by 95.74% to 27.2 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 27.2, 638.4, and 16.77 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | Cardio Diagnostics Holdings | 6.42 Mn | 835,350.96 | - | -435.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.76 |
| Mar 31, 2026 | -27.20 |
| Dec 31, 2025 | -638.40 |
| Sep 30, 2025 | -16.77 |
| Jun 30, 2025 | -2.91 |
| Mar 31, 2025 | -25.15 |
| Dec 31, 2024 | -484.94 |
| Sep 30, 2024 | -1.83 |
| Jun 30, 2024 | -1.53 |
| Mar 31, 2024 | -64.91 |
| Dec 31, 2023 | 0.23 |
| Sep 30, 2023 | -1.47 |
| Jun 30, 2023 | -2.43 |
| Mar 31, 2023 | -0.34 |
| Dec 31, 2022 | -407.97 |
| Dec 31, 2021 | -0.42 |